MedTrace Logo

Intercostal and Thoracic Cage Stretching on Chest Expansion , Dyspnea ,Oxygen Saturation in Asthma

NCT07331662 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-01-12

No results posted yet for this study

Summary

The rationale of this study is to clarify distinct role of these two stretching techniques in pulmonary rehabilitation. Insight gained from this research could provide evidence based recommendations for implementing these therapeutic approaches, aiming to optimize symptoms in asthma patients. so improved respiratory function and muscular flexibility can empower individuals with asthma to better manage their condition, weakening of muscles, airflow obstruction , reduce the effort required for daily activities and engage more fully in physical and everyday tasks thereby enhancing overall quality of life.

Conditions

Interventions

OTHER

thoracic cage stretching

thoracic cage stretching involve Sessions 4 times per week ,Intensity Stretch to the point of mild discomfort, but not pain. The goal is to feel a gentle stretch in the muscles being targeted, promoting flexibility without risking injury. Duration of Sessions: Each session should last about 30-40 minutes. Exercise Duration: Each exercise should involve 10repetitions ,Hold stretch for 10-30 sec. sets: 1-2, Rest for 1- 2 minutes between these two exercises. Types :chest opener stretch and overhead arm chest stretch

OTHER

intercostal stretching

intercostal stretching involve Sessions 4 times per week ,Intensity Stretch to the point of mild discomfort, but not pain. The goal is to feel a gentle stretch in the muscles being targeted, promoting flexibility without risking injury. Duration of Sessions: Each session should last about 30-40 minutes. Exercise Duration: Each exercise should involve 10repetitions ,Hold stretch for 10-30 sec. sets: 1-2, Rest for 1- 2 minutes between these two exercises. Types :lateral side bend stretch and torso rotational stretch

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Riffat Malik malik · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-17
Primary Completion
2025-12-17
Completion
2025-12-17

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07331662 on ClinicalTrials.gov